Mary Lynch

720 total citations
23 papers, 558 citations indexed

About

Mary Lynch is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mary Lynch has authored 23 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mary Lynch's work include Acute Myocardial Infarction Research (4 papers), Platelet Disorders and Treatments (3 papers) and Streptococcal Infections and Treatments (3 papers). Mary Lynch is often cited by papers focused on Acute Myocardial Infarction Research (4 papers), Platelet Disorders and Treatments (3 papers) and Streptococcal Infections and Treatments (3 papers). Mary Lynch collaborates with scholars based in United States, United Kingdom and New Zealand. Mary Lynch's co-authors include Harry L. T. Mobley, B L Pentecost, George L. Drusano, Robert A. Stockley, W A Littler, Andrew G. Plaut, William W. Bachovchin, George R. Flentke, Charles A. Kettner and Robert P. Hausinger and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Bacteriology.

In The Last Decade

Mary Lynch

23 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Lynch United States 13 146 96 81 75 72 23 558
R D Sublett United States 8 147 1.0× 14 0.1× 93 1.1× 66 0.9× 20 0.3× 8 513
A. Belaaouaj United States 8 172 1.2× 20 0.2× 107 1.3× 51 0.7× 51 0.7× 9 542
Elias A. Rahal Lebanon 15 157 1.1× 19 0.2× 34 0.4× 138 1.8× 93 1.3× 48 653
Marie‐Hélène Ruchaud‐Sparagano United Kingdom 15 168 1.2× 14 0.1× 24 0.3× 149 2.0× 50 0.7× 21 649
Jia‐Bin Sun Sweden 15 204 1.4× 19 0.2× 8 0.1× 81 1.1× 74 1.0× 24 910
Adam J. Poe United States 8 352 2.4× 90 0.9× 32 0.4× 36 0.5× 20 0.3× 12 618
Qinghua Hu China 17 318 2.2× 31 0.3× 207 2.6× 247 3.3× 55 0.8× 41 906
Lijun Zhou China 15 334 2.3× 8 0.1× 54 0.7× 131 1.7× 142 2.0× 40 938
T Todd Canada 8 247 1.7× 8 0.1× 37 0.5× 58 0.8× 100 1.4× 10 645
Yanfang Lu China 17 279 1.9× 27 0.3× 118 1.5× 116 1.5× 110 1.5× 30 832

Countries citing papers authored by Mary Lynch

Since Specialization
Citations

This map shows the geographic impact of Mary Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Lynch more than expected).

Fields of papers citing papers by Mary Lynch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Lynch. The network helps show where Mary Lynch may publish in the future.

Co-authorship network of co-authors of Mary Lynch

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Lynch. A scholar is included among the top collaborators of Mary Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Lynch. Mary Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fyfe, John C., et al.. (2012). A thyroid peroxidase (TPO) mutation in dogs reveals a canid-specific gene structure. Mammalian Genome. 24(3-4). 127–133. 6 indexed citations
2.
Lynch, Mary, Edward M. Fox, Louise O’Connor, Kieran Jordan, & Mary Murphy. (2011). Surveillance of Verocytotoxigenic Escherichia coli in Irish Bovine Dairy Herds. Zoonoses and Public Health. 59(4). 264–271. 23 indexed citations
3.
Bhat, M. A., Justin Denny, K. MacDonald, et al.. (2007). Escherichia coli O157:H7 infection associated with drinking raw milk - Washington and Oregon, November-December 2005. UWA Profiles and Research Repository (University of Western Australia). 56(8). 165–167. 38 indexed citations
4.
Parhami-Seren, Behnaz, Mary Lynch, Harvey D. White, & Guy L. Reed. (1995). Mapping the antigenic regions of streptokinase in humans before and after streptokinase therapy. Molecular Immunology. 32(10). 717–724. 17 indexed citations
5.
Lynch, Mary, et al.. (1995). Thrombolytic treatment and proteinuria.. Heart. 74(4). 354–357. 3 indexed citations
6.
Lynch, Mary, Michael D. Gammage, Patricia W. Lamb, M. Nattrass, & B L Pentecost. (1994). Acute Myocardial Infarction in Diabetic Patients in the Thrombolytic Era. Diabetic Medicine. 11(2). 162–165. 41 indexed citations
7.
Lynch, Mary, B L Pentecost, William A. Littler, & Robert A. Stockley. (1994). Overt and subclinical reactions to streptokinase in acute myocardial infarction. The American Journal of Cardiology. 74(9). 849–852. 7 indexed citations
8.
Lynch, Mary, B L Pentecost, W A Littler, & Robert A. Stockley. (1994). The significance of anti-streptokinase antibodies. Clinical & Experimental Immunology. 96(3). 427–431. 18 indexed citations
9.
Lynch, Mary, B L Pentecost, W A Littler, & Robert A. Stockley. (1993). Why do patients develop reactions to streptokinase?. Clinical & Experimental Immunology. 94(2). 279–285. 15 indexed citations
10.
Lynch, Mary, W A Littler, B L Pentecost, & Robert A. Stockley. (1991). Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.. Heart. 66(2). 139–142. 56 indexed citations
11.
Cottler‐Fox, Michele, Mary Lynch, Loni Pickle, et al.. (1991). Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels.. PubMed. 8(1). 27–33. 15 indexed citations
12.
Lynch, Mary, W A Littler, B L Pentecost, et al.. (1990). Antistreptokinase titres after intravenous streptokinase. The Lancet. 335(8688). 534–534. 2 indexed citations
13.
Hu, L T, et al.. (1990). Morganella morganii urease: purification, characterization, and isolation of gene sequences. Journal of Bacteriology. 172(6). 3073–3080. 37 indexed citations
14.
Bachovchin, William W., Andrew G. Plaut, George R. Flentke, Mary Lynch, & Charles A. Kettner. (1990). Inhibition of IgA1 proteinases from Neisseria gonorrhoeae and Hemophilus influenzae by peptide prolyl boronic acids.. Journal of Biological Chemistry. 265(7). 3738–3743. 90 indexed citations
15.
Burton, James, et al.. (1988). Substrate analog inhibitors of the IgA1 proteinases from Neisseria gonorrhoeae. Journal of Medicinal Chemistry. 31(8). 1647–1651. 12 indexed citations
16.
Mulrooney, Scott B., Mary Lynch, Harry L. T. Mobley, & Robert P. Hausinger. (1988). Purification, characterization, and genetic organization of recombinant Providencia stuartii urease expressed by Escherichia coli. Journal of Bacteriology. 170(5). 2202–2207. 43 indexed citations
17.
Lynch, Mary, George L. Drusano, & Harry L. T. Mobley. (1987). Emergence of resistance to imipenem in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 31(12). 1892–1896. 85 indexed citations
18.
Avadhani, Narayan G., Mary Lynch, & D.E. Buetow. (1971). Protein synthesis on polysomes in mitochondria isolated from Euglena gracilis. Experimental Cell Research. 69(1). 226–228. 8 indexed citations
19.
Crozier, D. N., et al.. (1970). Swiss agammaglobulinemia with hypoglycemia, osseous changes and eosinophilia.. PubMed. 103(1). 64–8 passim. 8 indexed citations
20.
Lynch, Mary, et al.. (1954). Fanconi's anaemia (aplastic anaemia with congenital abnormalities).. PubMed. 71(3). 273–6. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026